Buck Wealth Strategies’s Pfizer PFE Stock Holding History

Buck Wealth Strategies’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$82.5K	Buy	+3,426	New	+$89.6K	0.01%	284
2024 Q2	–	Sell	-295,419	Closed	-$8.2M	–	101
2024 Q1	$8.2M	Buy	295,419 +274,948	+1,343%	+$7.63M	2.82%	9
2023 Q4	$589K	Sell	20,471 -148,364	-88%	-$4.48M	0.22%	45
2023 Q3	$5.6M	Buy	168,835 +35,816	+27%	+$1.27M	2.25%	20
2023 Q2	$4.88M	Buy	133,019 +13,927	+12%	+$542K	2.12%	27
2023 Q1	$4.86M	Buy	+119,092	New	+$5.14M	2.37%	21
2022 Q3	$5.14M	Buy	+154,930	New	+$7.53M	2.4%	20

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Buck Wealth Strategies's PFE Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in Pfizer (PFE) in Q2 2026: 3,426 shares worth $82.5K. The stake represents 0.01% of the portfolio and ranks #284 among its holdings. This is a return to the name: Buck Wealth Strategies previously reported a position in PFE as recently as Q1 2024.

Buck Wealth Strategies first reported a position in PFE in Q3 2022 and has held it in 7 quarters since. The position peaked at $8.2M in Q1 2024. 2,835 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Buck Wealth Strategies held 3,426 shares of Pfizer worth $82.5K as of Q2 2026.
Pfizer was a new Buck Wealth Strategies position in Q2 2026.
Pfizer made up 0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #284 holding.
Buck Wealth Strategies first reported a position in Pfizer in Q3 2022 and has held it in 7 quarters since.
Buck Wealth Strategies's Pfizer position peaked at $8.2M in Q1 2024.
2,835 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.